Global prospective case series of ERCPs using a single-use duodenoscope

Abstract

Background The first commercialized single-use duodenoscope was cleared by the US Food and Drug Administration in December 2019. Data regarding endoscopic retrograde cholangiopancreatography (ERCP) using a single-use duodenoscope are needed on a broader range of cases conducted by endoscopists with varying levels of experience in a wide range of geographic areas.

Methods 61 endoscopists at 22 academic centers in 11 countries performed ERCP procedures in adult patients aged ≥ 18. Outcomes included ERCP completion for the intended indication, rate of crossover to a reusable endoscope, device performance ratings, and serious adverse events (SAEs).

Results Among 551 patients, 236 (42.8 %) were aged > 65, 281 (51.0 %) were men, and 256 (46.5 %) had their procedure as an inpatient. ERCPs included 196 (35.6 %) with American Society for Gastrointestinal Endoscopy complexity of grades 3–4. A total of 529 ERCPs (96.0 %) were completed: 503 (91.3 %) using only the single-use duodenoscope, and 26 (4.7 %) with crossover to a reusable endoscope. There were 22 ERCPs (4.0 %) that were not completed, of which 11 (2.0 %) included a crossover and 11 (2.0 %) were aborted cases (no crossover). Median ERCP completion time was 24.0 minutes. Median overall satisfaction with the single-use duodenoscope was 8.0 (scale of 1 to 10 [best]). SAEs were reported in 43 patients (7.8 %), including 17 (3.1 %) who developed post-ERCP pancreatitis.

Conclusions In academic medical centers over a wide geographic distribution, endoscopists with varying levels of experience using the first marketed single-use duodenoscope had good ERCP procedural success and reported high performance ratings for this device.

^* Deceased; this paper is dedicated to our friend and eminent colleague gastroenterologist Dr. Stuart Sherman.

Publikationsverlauf

Eingereicht: 13. März 2023

Angenommen nach Revision: 14. Juli 2023

Accepted Manuscript online:
18. Juli 2023

Artikel online veröffentlicht:
20. September 2023

• References

• 1 Kuduva Rajan S, Madireddy S, Jaladi PR. et al. Burdens of postoperative infection in endoscopic retrograde cholangiopancreatography inpatients. Cureus 2019; 11: e5237
• 2 Salminen P, Laine S, Gullichsen R. Severe and fatal complications after ERCP: analysis of 2555 procedures in a single experienced center. Surg Endosc 2008; 22: 1965-1970
• 3 Rerknimitr R, Fogel EL, Kalayci C. et al. Microbiology of bile in patients with cholangitis or cholestasis with and without plastic biliary endoprosthesis. Gastrointest Endosc 2002; 56: 885-889
• 4 US Health and Human Services. Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2013 (April 2013). Accessed: 21 July 2023. Available from: www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf
• 5 Kwakman JA, Erler NS, Vos MC. et al. Risk evaluation of duodenoscope-associated infections in the Netherlands calls for a heightened awareness of device-related infections: a systematic review. Endoscopy 2022; 54: 148-155
• 6 Barakat MT, Ghosh S, Banerjee S. Cost utility analysis of strategies for minimizing risk of duodenoscope-related infections. Gastrointest Endosc 2022; 95: 929-938 e922
• 7 Rauwers AW, Troelstra A, Fluit AC. et al. Independent root-cause analysis of contributing factors, including dismantling of 2 duodenoscopes, to investigate an outbreak of multidrug-resistant Klebsiella pneumoniae. Gastrointest Endosc 2019; 90: 793-804
• 8 Heuvelmans M, Wunderink HF, van der Mei HC. et al. A narrative review on current duodenoscope reprocessing techniques and novel developments. Antimicrob Resist Infect Control 2021; 10: 171
• 9 Muthusamy VR, Bruno MJ, Kozarek RA. et al. Clinical evaluation of a single-use duodenoscope for endoscopic retrograde cholangiopancreatography. Clin Gastroenterol Hepatol 2020; 18: 2108-2117 e2103
• 10 Bang JY, Hawes R, Varadarajulu S. Equivalent performance of single-use and reusable duodenoscopes in a randomised trial. Gut 2020; 70: 838-844
• 11 Napoleon B, Gonzalez JM, Grandval P. et al. Evaluation of the performances of a single-use duodenoscope: Prospective multi-center national study. Dig Endosc 2022; 34: 215-221
• 12 Slivka A, Ross AS, Sejpal DV. et al. Single-use duodenoscope for ERCP performed by endoscopists with a range of experience in procedures of variable complexity. Gastrointest Endosc 2021; 94: 1046-1055
• 13 US Food and Drug Administration. 510(k) number K201098: Ambu Duodeno System. Accessed: 21 July 2023. Available from: www.accessdata.fda.gov/cdrh_docs/pdf20/K201098.pdf
• 14 Ross AS, Bruno MJ, Kozarek RA. et al. Novel single-use duodenoscope compared with 3 models of reusable duodenoscopes for ERCP: a randomized bench-model comparison. Gastrointest Endosc 2020; 91: 396-403
• 15 US Food and Drug Administration. News & Events; FDA Newsroom; Press Announcements. FDA clears first fully disposable duodenoscope, eliminating the potential for infections caused by ineffective reprocessing (December 13, 2019). Accessed: 21 July 2023. Available from: www.fda.gov/news-events/press-announcements/fda-clears-first-fully-disposable-duodenoscope-eliminating-potential-infections-caused-ineffective
• 16 US Food and Drug Administration. FDA News. Boston Scientific Gains CE Mark for Single-Use Duodenoscope (January 24, 2020). Accessed: 21 July 2023. Available from: www.fdanews.com/articles/195625-boston-scientific-gains-ce-mark-for-single-use-duodenoscope
• 17 Boston Scientific Corporation. EXALT Model D Directions for Use. Accessed: 21 July 2023. Available from: www.bostonscientific.com/content/dam/Manuals/us/current-rev-en/50866130-01B_EXALT_Model_D_DFU_en-USA_s.pd
• 18 Testoni PA, Mariani A, Aabakken L. et al. Papillary cannulation and sphincterotomy techniques at ERCP: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy 2016; 48: 657-683
• 19 US Food and Drug Administration. News & Events; FDA Newsroom; Press Announcements. FDA clears first duodenoscope with disposable distal cap (March 26, 2018). Accessed: 21 July 2023. Available from: www.fda.gov/news-events/press-announcements/fda-clears-first-duodenoscope-disposable-distal-cap
• 20 US Food and Drug Administration. News & Events; FDA Newsroom; Press Announcements. FDA clears first duodenoscope with disposable elevator piece, reducing the number of parts needing disinfection (November 15, 2019). Accessed: 12 July 2023. Available from: www.fda.gov/news-events/press-announcements/fda-clears-first-duodenoscope-disposable-elevator-piece-reducing-number-parts-needing-disinfection
• 21 Rivallin P, Lorenzo D, Hedjoudje A. et al. Single-use duodenoscopes are an efficient tool for emergency ERCP in real life. Endosc Int Open 2022; 10: E1497-E1500
• 22 Bang JY, Sutton B, Hawes R. et al. Concept of disposable duodenoscope: at what cost?. Gut 2019; 68: 1915-1917
• 23 Forbes N, Elmunzer BJ, Allain T. et al. Effect of disposable elevator cap duodenoscopes on persistent microbial contamination and technical performance of endoscopic retrograde cholangiopancreatography: the ICECAP Randomized Clinical Trial. JAMA Intern Med 2023; 183: 191-200
• 24 Ofosu A, Ramai D, Mozell D. et al. Analysis of reported adverse events related to single-use duodenoscopes and duodenoscopes with detachable endcaps. Gastrointest Endosc 2022; 96: 67-72
• 25 Trindade AJ, Copland A, Bhatt A. et al. Single-use duodenoscopes and duodenoscopes with disposable end caps. Gastrointest Endosc 2021; 93: 997-1005
• 26 US Food and Drug Administration. Center for Devices and Radiological Health United States: Inspections, Compliance, Enforcement, and Criminal Investigations; Compliance Actions and Activities; Warning Letters. Warning Letter, Olympus Medical Systems Corp. MARCS-CMS 654013 (March 15, 2023). Accessed: 21 July 2023. Available from: www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/olympus-medical-systems-corp-654013-03152023
• 27 Le NNT, Hernandez LV, Vakil N. et al. Environmental and health outcomes of single-use versus reusable duodenoscopes. Gastrointest Endosc 2022; 96: 1002-1008
• 28 US Food and Drug Administration. News & Events; FDA Newsroom; Press Announcements. FDA Continues Efforts to Support Innovation in Medical Device Sterilization (August 3, 2022). Accessed: 21 July 2023. Available from: www.fda.gov/news-events/press-announcements/fda-continues-efforts-support-innovation-medical-device-sterilization
• 29 Adler DG, Lieb 2nd JG. et al. Quality indicators for ERCP. Gastrointest Endosc 2015; 81: 54-66
• 30 Domagk D, Oppong KW, Aabakken L. et al. Performance measures for endoscopic retrograde cholangiopancreatography and endoscopic ultrasound: A European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. United European Gastroenterol J 2018; 6: 1448-1460
• 31 Alberca de Las Parras F, Lopez-Picazo J, Perez Romero S. et al. Quality indicators for endoscopic retrograde cholangiopancreatography. The procedure of endoscopic retrograde cholangiopancreatography. . Rev Esp Enferm Dig 2018; 110: 658-666
• 32 Andriulli A, Loperfido S, Napolitano G. et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol 2007; 102: 1781-1788